Hints and tips:
...AstraZeneca Q4, British American Tobacco FY, CMC Markets trading update and revised outlook for 2024, ConocoPhillips Q4, Compass Group Q1 trading update and AGM, Crédit Agricole FY, Honda Q3, Kering FY, L’...
...This should add to pressure on an equity story that we see beset by; 1) skepticism on mid-term growth rate, 2) earnings risks from an already well optimized P&L, 3) overhang from potential disposal by major...
...A: Chicken Run A family-owned business wins the exclusive contract to operate a pharmaceutical production concession....
...The consultancy last year agreed to pay almost $574mn to settle claims brought by US states alleging that McKinsey’s advice to pharmaceutical companies, including Purdue Pharma, contributed to America’s...
...Anyway, here are names and links — we’ll let you make your own mind up: Liquid 2 Venture Fund III L.P . . . . Lake Nona Fund / LN Sports & Health Tech Fund I, LP . . ....
...Not many managers are ready to do this — though some are beginning to ask their clients what they want (L&G and Aviva are ahead of the game)....
...If values are not enough for the likes of McKinsey to make better choices, then a pain in the P&L may be the only behavioural cue that really works....
...(Tamami Shimizuishi) French citizens demand more from climate change bill It was dubbed L'Affaire du Siècle, the case of the century....
...“It took about two years until we saw this effect going through the P&L,” he said. “I think that is a good estimate of what we have to expect for the US.”...
...Medco, led by Mark Timney, former CEO of controversial US drugs group Purdue, has chosen its moment well. Novartis now has a lot to prove....
...L’Oréal Sector: cosmetics / HQ: Paris, France Key stat: Online sales jumped 53 per cent in the first quarter....
...That decline is far less than the wider S&P 500 pharmaceuticals index, which is down 28 per cent. Mr Younger says reputation is divided into capability and character....
...The Reckitt penalty dwarfs the $600m paid by Purdue Pharma, which pioneered the most popular opioid drug known as OxyContin....
...The S&P 500 pharmaceuticals index is down 4 per cent over the same period. The companies intend to push back strongly. They point out regulators approved their drugs....
...Company commentary supports our view of limited direct impact to P&C : Hannover Re: noted a potential €200m loss across P&C and L&H; Munich Re: noted a €500m loss should all the events it covers for communicable...
...However, other research shows innovative founders spread across S&P 500 companies: in 2016, three professors at Purdue’s Krannert School of Management calculated that companies in the index with a founder...
...second large pharmaceutical company that makes opioids: Rhodes Pharma....
...HBC has been under pressure to reduce the strain on its balance sheet; both Moody's and S&P Global rate it within junk territory. This deal will go some way to accomplishing that....
...L’Oréal has the distinction of being the company that Comgest has held the longest, with the original investment made in 1991....
...“Otherwise, you could put a heavy weight on operational and P&L experience, but it doesn’t mean you have got the CEO [who will last] for the next three to five years”....
...Emma Walmsley, who took over from Sir Andrew Witty as chief executive in April, worked for L’Oréal for 17 years before joining the pharmaceuticals company in 2010. —————————- For its 130 senior executives...
...company’s profit & loss (P&L) account....
...Shares of L Brands rose more than 4 per cent to $89.28 after the company behind Victoria’s Secret and La Senza reported August sales that topped analysts’ forecasts....
...Biocryst Pharmaceuticals was the biggest faller, down 18 per cent to $9.75....
...Bioprinting is also being looked at by pharmaceuticals companies as a way of speeding up and lowering the cost of drug development and testing....
International Edition